BofA raises Roblox stock price target on viral hit potential
Source: Investing.com

BofA raised Roblox's price target to $48 from $44 while retaining a Neutral rating, versus a $45.50 share price, after increasing its valuation multiple to 20x calendar-2027 EBITDA. The firm sees a higher likelihood of viral game hits from improved personalized content discovery, supporting its Q4 and 2027 forecasts; Roblox reported 41% revenue growth over the past 12 months. Offsetting factors include potential competition from GTA 6, user and algorithm concerns flagged by Jefferies, and a separate Oppenheimer target cut to $50 from $82 despite its Outperform rating.
Analysis
The investable issue is not whether discovery can create another breakout title, but whether Roblox can retain the incremental engagement at acceptable creator incentives and infrastructure cost. A less restrictive recommendation system may lift bookings faster than it lifts EBITDA: viral experiences concentrate traffic, raise trust-and-safety moderation load, and can increase payouts to developers. The market is already valuing a favorable 2027 outcome near the revised target, so near-term upside requires evidence that monetization per incremental hour is stable rather than simply higher user concurrency.
GTA 6 is a meaningful attention shock rather than a direct product substitute. Its launch could pressure older, higher-spending Roblox cohorts and creator activity for several weeks, while potentially reinforcing Roblox's differentiated role for younger, social, rapidly refreshed content. The more material medium-term risk is platform safety: enforceable remediation can force age-assurance, messaging, and discovery changes that reduce conversion or session depth before benefits from greater parent trust accrue. This is a 6-18 month margin and multiple risk, not merely a headline risk.
Consensus appears too focused on hit velocity and too little on the durability of hit economics. A discovery improvement that broadens the long tail would be structurally positive because it diversifies bookings away from a small number of experiences; one that repeatedly funnels users into a few viral games creates a transient growth signal and stronger bargaining power for top creators. The next earnings release and disclosed bookings/DAU, hours/DAU, and adjusted-EBITDA conversion are the clean falsification points: engagement growth without bookings leverage should cap multiple expansion.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.18
Ticker Sentiment
Key Decisions for Investors
- Do not chase RBLX above the current analyst-target area. Establish a 1-3 month watch position only after earnings if bookings growth exceeds guidance while adjusted-EBITDA margin is maintained or raised; a 10-15% drawdown on safety-remediation concern offers better entry than paying for unverified 2027 hit assumptions.
- For existing RBLX longs, use a defined-risk collar through the GTA 6 launch window: retain upside via stock or calls while buying 3-6 month downside protection. Reduce exposure if management indicates higher creator payouts, moderation costs, or weaker monetization of incremental engagement.
- Relative-value setup: long RBLX versus short TTWO only if GTA 6 launch timing becomes firm and RBLX engagement data remains resilient into that date. The thesis is Roblox's audience segmentation, not a claim that it is immune; close the pair if older-user hours or bookings per DAU deteriorate in the pre-launch period.
- Treat BAC, C, JEF, and OPY commentary as non-actionable for their equities. Analyst target changes are unlikely to be earnings-relevant to the brokers absent a broader capital-markets or trading-volume signal.
More News
- Bank of America says we are overdue for a stock pullback
- Bowman’s go-shop period ends with no alternative bids
- AI too vital to slow, too fast to regulate: BofA
- Why is Adobe stock climbing today?
- Lucid Capital Markets initiates Faeth Therapeutics stock with buy
- Tyra Biosciences prices $400 million stock offering